Ensemble pharmaceutical and Novartis reach a global strategic cooperation
-
Last Update: 2013-08-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: Biovalley 2013-8-7 ensemble pharmaceutical announced today that it has reached a two-way global strategic cooperation with Novartis to develop an oral IL-17 antagonist project and develop small molecule drugs targeting specific disease targets using ensemble pharmaceutical's innovative drug discovery chemistry platform The financial terms of the agreement have not been disclosed At present, the large circle drug discovery platform of enssemble pharmaceutical has attracted the interest of several pharmaceutical giants, and has reached cooperation with Roche, Boehringer Ingelheim, BMS and Pfizer.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
